Dr. Henchcliffe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Plaza Drive
Irvine, CA 92697Phone+1 949-824-8600
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Neuromuscular Medicine (Neurology), 2001 - 2003
- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1998 - 2001
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1997 - 1998
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1997
- University of California, BerkeleyPost-Doctoral Fellowship, 1989 - 1992
- University of Oxford, Sir William Dunn School of PathologyD.Phil., Molecular/Cell Biology, 1985 - 1988
- University of Oxford, Keble CollegeBA, Biochemistry, 1st Class Honors, 1981 - 1985
Certifications & Licensure
- CA State Medical License 2020 - 2026
- NY State Medical License 1998 - 2021
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Fellow (FAAN) American Academy of Neurology
- Fellow (FANA) American Neurological Association
- Daisy and Paul Soros Clinical Scholar in Neurology Weill Cornell Medical College, 2006-2012
- Join now to see all
Clinical Trials
- Psychiatric and Cognitive Manifestations of Parkinson's Disease Start of enrollment: 2006 Jun 01
- Risk Factors for Progressive Supranuclear Palsy (PSP) Start of enrollment: 2006 Aug 01
- Study to Evaluate SYN115 in Parkinson's Disease Start of enrollment: 2008 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 108 citationsCerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.Jennifer G. Goldman, Howard Andrews, Amy W. Amara, Anna Naito, Roy N. Alcalay
Movement Disorders. 2018-02-01 - 90 citationsEffect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical TrialMichael A. Schwarzschild, Alberto Ascherio, Cindy Casaceli, Gary C. Curhan, Rebecca Fitzgerald
JAMA. 2021-09-14 - 551 citationsMitochondrial biology and oxidative stress in Parkinson disease pathogenesisClaire Henchcliffe, M. Flint Beal
Nature Clinical Practice. Neurology. 2008-11-01
Press Mentions
- BlueRock Therapeutics to Incorporate Wearable and Invisible Contactless Digital Health Technologies from Rune Labs and Emerald Innovations in Parkinson’s Disease Clinical TrialMarch 14th, 2023
- BlueRock Therapeutics Announces Completion of Enrollment of Phase 1 Trial in Patients with Parkinson's DiseaseMay 31st, 2022
- Scientists Reverse Motor Symptoms in Parkinson's Disease ModelAugust 6th, 2020
- Join now to see all
Committees
- Member, ANA Career Development Subcommittee 2020 - Present
- Committee Member, AAN Education Committee 2017 - 2021
Professional Memberships
- Fellow
- Member
- American Neurological AssociationFellow
- International Society for Stem Cell Research (ISSCR)Member
- American Society for Gene and Cell Therapy (ASGCT)Member
External Links
- Faculty profilehttps://www.faculty.uci.edu/profile.cfm?faculty_id=6921
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: